Brain Advance Access published online on May 9, 2006
Brain, doi:10.1093/brain/awl103
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Neurology and Neurosurgery, Neuroscience Area, Clinica Universitaria and Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain; Present address: Section of Neurology, Hospital de Fuenlabrada Madrid, Spain
* To whom correspondence should be addressed. The pathophysiology of levodopa-induced dyskinesias (LID) in Parkinson's disease is not well understood. We have recorded local field potentials (LFP) from macroelectrodes implanted in the subthalamic nucleus (STN) of 14 patients with Parkinson's disease following surgical treatment with deep brain stimulation. Patients were studied in the Off medication state and in the On motor state after administration of levodopa-carbidopa (po) or apomorphine (sc) that elicited dyskinesias in 11 patients. The logarithm of the power spectrum of the LFP in selected frequency bands (4-10, 11-30 and 60-80 Hz) was compared between the Off and On medication states. A peak in the 11-30 Hz band was recorded in the Off medication state and reduced by 45.2% (P < 0.001) in the On state. The On was also associated with an increment of 77. 6% (P < 0.001) in the 4-10 Hz band in all patients who showed dyskinesias and of 17.8% (P < 0.001) in the 60-80 Hz band in the majority of patients. When dyskinesias were only present in one limb (n = 2), the 4-10 Hz peak was only recorded in the contralateral STN. These findings suggest that the 4-10 Hz oscillation is associated with the expression of LID in Parkinson's disease.
Received October 12, 2005
Revised December 24, 2005
Accepted March 28, 2006
Article
Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease
F. Alonso-Frech 1,
I. Zamarbide 2,
M. Alegre 3,
M. C. Rodríguez-Oroz 3,
J. Guridi 3,
M. Manrique 3,
M. Valencia 3,
J. Artieda 3,
and
J. A. Obeso 3 *
2 Department of Neurology and Neurosurgery, Neuroscience Area, Clinica Universitaria and Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain; Present address: Section of Neurology, Hospital Universitario de Guadalajara Guadalajara, Spain
3 Department of Neurology and Neurosurgery, Neuroscience Area, Clinica Universitaria and Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain
J. A. Obeso, E-mail: jobeso{at}unav.es
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. J. Lehmkuhle, S. S. Bhangoo, and D. R. Kipke The Electrocorticogram Signal Can Be Modulated With Deep Brain Stimulation of the Subthalamic Nucleus in the Hemiparkinsonian Rat J Neurophysiol, September 1, 2009; 102(3): 1811 - 1820. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Akbari and S. Gharibzadeh {beta} Oscillations as the Cause of Both Hyper- and Hypokinetic Symptoms of Movement Disorders J Neuropsychiatry Clin Neurosci, August 1, 2009; 21(3): 352 - 352. [Full Text] [PDF] |
||||
![]() |
A. Eusebio, A. Pogosyan, S. Wang, B. Averbeck, L. D. Gaynor, S. Cantiniaux, T. Witjas, P. Limousin, J.-P. Azulay, and P. Brown Resonance in subthalamo-cortical circuits in Parkinson's disease Brain, August 1, 2009; 132(8): 2139 - 2150. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Weinberger, W. D. Hutchison, A. M. Lozano, M. Hodaie, and J. O. Dostrovsky Increased Gamma Oscillatory Activity in the Subthalamic Nucleus During Tremor in Parkinson's Disease Patients J Neurophysiol, February 1, 2009; 101(2): 789 - 802. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schuster, A. Nadjar, J. T. Guo, Q. Li, C. Ittrich, B. Hengerer, and E. Bezard The 3-Hydroxy-3-Methylglutaryl-CoA Reductase Inhibitor Lovastatin Reduces Severity of L-DOPA-Induced Abnormal Involuntary Movements in Experimental Parkinson's Disease J. Neurosci., April 23, 2008; 28(17): 4311 - 4316. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lalo, S. Thobois, A. Sharott, G. Polo, P. Mertens, A. Pogosyan, and P. Brown Patterns of Bidirectional Communication between Cortex and Basal Ganglia during Movement in Patients with Parkinson Disease J. Neurosci., March 19, 2008; 28(12): 3008 - 3016. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Androulidakis, A. A. Kuhn, C. Chu Chen, P. Blomstedt, F. Kempf, A. Kupsch, G.-H. Schneider, L. Doyle, P. Dowsey-Limousin, M. I. Hariz, et al. Dopaminergic therapy promotes lateralized motor activity in the subthalamic area in Parkinson's disease Brain, February 1, 2007; 130(2): 457 - 468. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Weinberger, N. Mahant, W. D. Hutchison, A. M. Lozano, E. Moro, M. Hodaie, A. E. Lang, and J. O. Dostrovsky Beta Oscillatory Activity in the Subthalamic Nucleus and Its Relation to Dopaminergic Response in Parkinson's Disease J Neurophysiol, December 1, 2006; 96(6): 3248 - 3256. [Abstract] [Full Text] [PDF] |
||||



